← Back to headlines
Hims Expansion Faces Challenges in Risky GLP-1 Business
Hims' expansion efforts may not materialize quickly enough to capitalize on the growing but risky GLP-1 weight-loss drug market.
2 Mar, 14:16 — 2 Mar, 14:16
Sources
Showing 1 of 1 sources



